The cell culture market was worth around USD 16 billion in 2014. It is estimated to surpass USD 36 billion by 2022. This could be ascribed to requirement for biopharmaceutical development, protein production, and vaccine research. These activities depend on cytological research and developments wherein cell culture is of prime significance.
For Market Research Report on “Cell Culture Market ” Visit -http://www.grandviewresearch.com/industry-analysis/cell-culture-market
Growing genetic engineering, genomic and proteomic profiling, and recombinant DNA technology are making cell culture indispensible. Ongoing expansion of cell culture applications and procedures will contribute to stable and considerable expansion in the cell culture market in the years ahead.
The market is classified according to products, consumables, applications, and regions. Products are incubators, pipetting instruments, culture systems, cyrostorage equipment, and biosafety equipment. Culture systems are split into culture bags, roller bottles, culture plates, T-flasks, bioreactors, and centrifuges. They accounted for over half of the total revenues in 2014.
The equipments included in culture systems are integral to any cell culture process. Culture systems would generate strong revenues in the future. Consumables comprise media, sera, and reagents. Sera held about 51% of the market in 2014. This may be attributed to robust demand for serum in the creation of cell cultures. Commercialization of serum-free sera will also assist Sera growth.
Applications of the cell culture market include gene therapy, cancer research, toxicity testing, biopharmaceuticals, drug development, vaccine production, and tissue culture & testing. Biopharmaceuticals was the leader in terms of revenues in 2014. Innovations in genetic engineering have triggered high usage of protein-based biopharmaceuticals. This would drive the sector in the coming years. Vaccine production stood second in 2014.
With respect to regions, North America was the cell culture market leader in 2014. Cell culture finds applications in Canada and the U.S. due to automated cell culture techniques and stem cell therapies. Asia Pacific is predicted to be propelled by automatic single cell examination and segregation systems for stem cell research. This will be observed particularly in Japan.
Leading players of the worldwide cell culture market comprise General Electric, Thermo Fischer Scientific, Sigma-Aldrich Co., Sartorius, and Merck. They are engaged in the development of 3D cell culture techniques to attain further growth.
Information Source: Radiants Insights